Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by MayTech Global Investments LLC

MayTech Global Investments LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 68,064 shares of the medical equipment provider's stock after purchasing an additional 3,345 shares during the period. Intuitive Surgical accounts for approximately 4.2% of MayTech Global Investments LLC's investment portfolio, making the stock its 10th biggest holding. MayTech Global Investments LLC's holdings in Intuitive Surgical were worth $35,527,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $82,517,000. Sycomore Asset Management increased its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. raised its stake in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. Finally, Czech National Bank lifted its holdings in shares of Intuitive Surgical by 6.9% during the fourth quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider's stock worth $40,309,000 after purchasing an additional 4,970 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $561.43 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $379.67 and a 1-year high of $616.00. The stock's 50 day simple moving average is $500.80 and its 200-day simple moving average is $535.38. The company has a market cap of $201.23 billion, a PE ratio of 87.59, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the firm earned $1.50 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently weighed in on ISRG. Robert W. Baird cut their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Barclays cut their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Finally, Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $598.95.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 2,401 shares of the company's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company's stock, valued at approximately $205,093. This represents a 87.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,636 shares of company stock valued at $16,829,815 in the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.